Walden Group Healthcare M&A Blog

Teladoc Health to Buy Livongo in $18.5b Mega-Deal

8/12/2020
Teladoc (NYSE: TDOC), a $553.3m telemedicine provider, is buying Livongo (Nasdaq: LVGO), a $170.2m digital health and virtual diabetes coaching company, in an $18.5b merger, to create a company with a combined $1.3b in revenue in 2020, up 85% YOY. This is the largest digital health deal in history, ringing in at a purchase price for Livongo at...
Read More
Creo Medical Acquires Albyn Medical for $29.3m

8/3/2020
Creo Medical, a UK-based developer of endoscopic microwave and radiofrequency ablation technologies, is acquiring Albyn Medical, a Spain-based manufacturer of branded and third-party gastroenterology, urology and endoscopy products including biopsy forceps, snares, catheters, tubes and valves. The acquisition expands Creo’s GI product suite and...
Read More
Nexelis Acquires Integrated Bioanalytical CRO AIT Bioscience

7/27/2020
Nexelis, a Canada-based provider of advanced assay development and laboratory testing services in infectious, oncologic, and metabolic diseases and an Ampersand Capital Partners portfolio company, has acquired AIT Bioscience, LLC, a U.S.-based integrated bioanalytical laboratory with liquid chromatography–mass spectrometry (LC-MS) and...
Read More
Medtronic to Acquire Medicrea

7/20/2020
Medtronic plc, a major, $28.9b medical device maker of cardiovascular, orthopedic, spinal and other surgical devices, is buying Medicrea, a France-based developer of patient-specific, 3D-printed titanium spinal implants and related workflow software that helps surgeons use predictive modeling to digitally reconstruct a patient’s spine profile....
Read More
LGC Limited Purchases The Native Antigen Company

7/15/2020
UK-based producer of diagnostic reagents LGC has purchased The Native Antigen Company (NAC), a UK-based supplier of recombinant viral and bacterial antigens, antibodies and immunoassays. NAC was among the first companies to offer antigens for SARS-COV-2 on a global scale. The deal adds >60 viral and infectious disease products to...
Read More